Pharmaron controlling shareholder adjusts share pledge portfolio

Pharmaron Beijing Co., Ltd. announced that its controlling person, Lou Xiaoqiang, has completed a new share pledge and released a previous pledge. Mr. Lou pledged 12 million shares, representing 19.82% of his total holdings and 0.67% of the company's total share capital. The pledge, effective September 25, 2025, with a maturity date of September 24, 2026, was for replacing existing financing and institution financing, with Huatai Securities Co., Ltd. as the pledgee.

Concurrently, Mr. Lou unpledged a total of 15.15 million shares. This comprised two tranches: 13.15 million shares (21.72% of his holdings, 0.74% of total share capital) released on May 29, 2025, and an additional 2 million shares (3.30% of his holdings, 0.11% of total share capital) released on September 26, 2025. Both unpledged amounts were previously held by Huatai Securities (Shanghai) Asset Management Co., Ltd.

Following these transactions, Mr. Lou Xiaoqiang's pledged shares stand at 24.27 million, representing 40.09% of his holdings and 1.36% of the company's total share capital. The company clarified that the pledged shares do not carry obligations for performance compensation related to major asset restructurings and the transactions will not impact the company's operations or governance.